Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Transplantation. 2010 Sep 15;90(5):483–493. doi: 10.1097/TP.0b013e3181e98d51

Figure 3. Results of measurement of coagulation factors in healthy humans, baboons, and pigs, and after orthotopic genetically-engineered pig liver transplantation in baboons.

Figure 3

(A) Factor II (prothrombin), (B) Factor V (proaccelerin), (C) Factor VII (proconvertin), (D) Factor VIII (anti-hemophilic factor), (E) Factor IX (Christmas factor), (F) Factor X (Stuart-Prower factor), (G) Factor XI (plasma thromboplastin antecedent), and (H) Factor XII (Hageman factor). (P = mean genetically-engineered pig values with standard deviation; B = mean baboon values with standard deviation; H = human range. B18508 was treated with cobra venom factor).